Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs Placebo in Japanese Early RA
NCT00870467Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2009
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Placebo + MTX with Adalimumab + MTX (2 arms). Primary endpoint: Modified Total Sharp X-Ray Score at 26 weeks. Started Mar 2009; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00870467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870467.